Literature DB >> 24574746

Efficacy of fermented milk and whey proteins in Helicobacter pylori eradication: a review.

Aarti Sachdeva1, Swapnil Rawat1, Jitender Nagpal1.   

Abstract

Helicobacter pylori (H. pylori) eradication is considered a necessary step in the management of peptic ulcer disease, chronic gastritis, gastric adenocarcinoma and mucosa associated lymphoid tissue lymphoma. Standard triple therapy eradication regimens are inconvenient and achieve unpredictable and often poor results. Eradication rates are decreasing over time with increase in antibiotic resistance. Fermented milk and several of its component whey proteins have emerged as candidates for complementary therapy. In this context the current review seeks to summarize the current evidence available on their role in H. pylori eradication. Pertinent narrative/systematic reviews, clinical trials and laboratory studies on individual components including fermented milk, yogurt, whey proteins, lactoferrin, α-lactalbumin (α-LA), glycomacropeptide and immunoglobulin were comprehensively searched and retrieved from Medline, Embase, Scopus, Cochrane Controlled Trials Register and abstracts/proceedings of conferences up to May 2013. A preponderance of the evidence available on fermented milk-based probiotic preparations and bovine lactoferrin suggests a beneficial effect in Helicobacter eradication. Evidence for α-LA and immunoglobulins is promising while that for glycomacropeptide is preliminary and requires substantiation. The magnitude of the potential benefit documented so far is small and the precise clinical settings are ill defined. This restricts the potential use of this group as a complementary therapy in a nutraceutical setting hinging on better patient acceptability/compliance. Further work is necessary to identify the optimal substrate, fermentation process, dose and the ideal clinical setting (prevention/treatment, first line therapy/recurrence, symptomatic/asymptomatic, gastritis/ulcer diseases etc.). The potential of this group in high antibiotic resistance or treatment failure settings presents interesting possibilities and deserves further exploration.

Entities:  

Keywords:  Bovine lactoferrin; Fermented milk; Glycomacropeptide; Helicobacter pylori; Immunoglobulin; Whey proteins; α-Lactalbumin

Mesh:

Substances:

Year:  2014        PMID: 24574746      PMCID: PMC3921482          DOI: 10.3748/wjg.v20.i3.724

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  54 in total

1.  A new system for grading recommendations in evidence based guidelines.

Authors:  R Harbour; J Miller
Journal:  BMJ       Date:  2001-08-11

Review 2.  Therapeutic applications of whey protein.

Authors:  Keri Marshall
Journal:  Altern Med Rev       Date:  2004-06

3.  [Inhibiting action of glycomacropeptide on stomach secretion induced by various humoral stimulants].

Authors:  L S Vasilevskaia; E Ia Stan; M P Chernikov; G K Shlygin
Journal:  Vopr Pitan       Date:  1977 Jul-Aug

4.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

5.  Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori.

Authors:  Kuan-Yuan Wang; Shui-Nin Li; Chiang-Shin Liu; Daw-Shyong Perng; Yu-Chung Su; Deng-Chyang Wu; Chang-Ming Jan; Chun-Huang Lai; Tsu-Nai Wang; Wen-Ming Wang
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

Review 6.  Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant.

Authors:  J H Brock
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

7.  Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects.

Authors:  A Cats; E J Kuipers; M A R Bosschaert; R G J Pot; C M J E Vandenbroucke-Grauls; J G Kusters
Journal:  Aliment Pharmacol Ther       Date:  2003-02       Impact factor: 8.171

8.  Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis.

Authors:  D Pantoflickova; I Corthésy-Theulaz; G Dorta; M Stolte; P Isler; F Rochat; M Enslen; A L Blum
Journal:  Aliment Pharmacol Ther       Date:  2003-10-15       Impact factor: 8.171

9.  Use of bovine lactoferrin for Helicobacter pylori eradication.

Authors:  F Di Mario; G Aragona; N Dal Bò; G M Cavestro; L Cavallaro; V Iori; G Comparato; G Leandro; A Pilotto; A Franzè
Journal:  Dig Liver Dis       Date:  2003-10       Impact factor: 4.088

10.  Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.

Authors:  B-S Sheu; J-J Wu; C-Y Lo; H-W Wu; J-H Chen; Y-S Lin; M-D Lin
Journal:  Aliment Pharmacol Ther       Date:  2002-09       Impact factor: 8.171

View more
  7 in total

Review 1.  α-Lactalbumin, Amazing Calcium-Binding Protein.

Authors:  Eugene A Permyakov
Journal:  Biomolecules       Date:  2020-08-20

Review 2.  Dietary amelioration of Helicobacter infection.

Authors:  Jed W Fahey; Katherine K Stephenson; Alison J Wallace
Journal:  Nutr Res       Date:  2015-03-06       Impact factor: 3.315

Review 3.  Management of multi-drug resistant Helicobacter pylori infection by supplementary, complementary and alternative medicine; a review.

Authors:  Nasim Rezaeimanesh; Nastaran Farzi; Samira Pirmanesh; Saeed Emami; Abbas Yadegar
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

4.  Characterization of proteolytic degradation products of vaginally administered bovine lactoferrin.

Authors:  Thomas P Hopp; Klaudyna Spiewak; Maura-Ann H Matthews; Zafeiria Athanasiou; Richard S Blackmore; Gary A Gelbfish
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.240

Review 5.  Lactoferrin from Milk: Nutraceutical and Pharmacological Properties.

Authors:  Francesco Giansanti; Gloria Panella; Loris Leboffe; Giovanni Antonini
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-27

Review 6.  Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine.

Authors:  Natascia Bruni; Maria Teresa Capucchio; Elena Biasibetti; Enrica Pessione; Simona Cirrincione; Leonardo Giraudo; Antonio Corona; Franco Dosio
Journal:  Molecules       Date:  2016-06-11       Impact factor: 4.411

7.  Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.

Authors:  Antonio Francesco Ciccaglione; Mara Di Giulio; Silvia Di Lodovico; Emanuela Di Campli; Luigina Cellini; Leonardo Marzio
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.